Mutation profile and prognostic relevance in elderly patients with de novo acute myeloid leukemia treated with decitabine-based chemotherapy.
CONCLUSION: This study comprehensively analyzed the prognostic implications of gene mutations in elderly AML patients under decitabine-based treatment modality. Identification of genetic biomarkers to predict the subgroup of elderly AML patients who can benefit from decitabine-based regimens might have an immediate clinical utility to optimize the treatment of elderly AML patients.
PMID: 32730663 [PubMed - as supplied by publisher]
Source: International Journal of Laboratory Hematology - Category: Hematology Authors: Ni J, Hong J, Long Z, Li Q, Xia R, Zeng Q Tags: Int J Lab Hematol Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Genetics | Hematology | Laboratory Medicine | Leukemia | Study